Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New schedule milestones were added to the study record, including the latest update date and revised completion timelines that extend into 2027. Older milestone dates were removed, signaling an update to the study's expected timeline and status.
    Difference
    0.3%
    Check dated 2026-07-21T11:54:17.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.0 to v3.6.3, indicating a newer revision of the study record page. This reflects internal maintenance and does not change the study data or primary content.
    Difference
    0.1%
    Check dated 2026-06-30T01:00:32.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Introduces a recruitment notice and new navigation aids to help users understand and join the study; includes a minor formatting change to the Intervention header and a new revision tag (v3.6.0).
    Difference
    0.4%
    Check dated 2026-06-15T22:56:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4. This reflects a new build/version of the page.
    Difference
    0.1%
    Check dated 2026-06-09T01:41:22.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page revision tag has been updated to v3.5.4, replacing v3.5.3, signaling a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-05-18T13:52:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The page now shows an updated “Revision” identifier for the ClinicalTrials.gov interface (v3.5.3 instead of v3.5.2), reflecting a software/content template update rather than a change to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-27T07:33:36.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.